Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13

IMPORTANCE: Functional end points for clinical trials investigating the efficacy of emerging treatments for Stargardt disease type 1 (STGD1) are needed. OBJECTIVE: To assess the yearly rate of change of macular function in patients with STGD1 using microperimetry. DESIGN, SETTING, AND PARTICIPANTS:...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Ophthalmol
Autori principali: Schönbach, Etienne M., Strauss, Rupert W., Muñoz, Beatriz, Wolfson, Yulia, Ibrahim, Mohamed A., Birch, David G., Zrenner, Eberhart, Sunness, Janet S., Ip, Michael S., Sadda, SriniVas R., West, Sheila K., Scholl, Hendrik P. N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7256863/
https://ncbi.nlm.nih.gov/pubmed/32463436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2020.1735
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi